Home › Funds › CADEN CAPITAL PARTNERS, LP › STE

CADEN CAPITAL PARTNERS, LP position in STE

STERIS PLC · Health Care

CADEN CAPITAL PARTNERS, LP reported holding 946 shares of STE (STERIS PLC) in its Q2 2026 13F filing — a position valued at US$199K, representing 2.40% of its reported portfolio and ranking #32 among its reported holdings. CADEN CAPITAL PARTNERS, LP has disclosed STE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)946 sh
Reported value held$199.20K
Portfolio Weight2.40%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CADEN CAPITAL PARTNERS, LP's STE position evolved

CADEN CAPITAL PARTNERS, LP first disclosed a stake in STE in Q3 2023 at 45,736 shares (US$10.0M). The position peaked in Q4 2024 at 175,358 shares, worth US$36.0M. Across 12 filings, CADEN CAPITAL PARTNERS, LP increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 946 shares valued at US$199K. Notable position changes include a 119% increase in Q4 2024 (shares rose 10% over the following quarter), a 459% increase in Q2 2025 (shares rose 3% over the following quarter), a 97% trim in Q4 2025 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 45.74K $10.04M New
Q4 2023 82.31K $18.10M Add
Q1 2024 86.94K $19.55M Add
Q2 2024 113.64K $24.95M Add
Q3 2024 79.98K $19.40M Reduce
Q4 2024 175.36K $36.05M Add
Q1 2025 25.00K $5.67M Reduce
Q2 2025 139.73K $33.56M Add
Q3 2025 124.73K $30.86M Reduce
Q4 2025 3.17K $804.16K Reduce
Q1 2026 946 $209.19K Reduce
Q2 2026 946 $199.20K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STE and 13F data

STE (STERIS PLC) is a Health Care company. 27 other funds we track also report a position in STE — the largest reported positions include Orbis Allan Gray Ltd (US$563.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$480.2M), Select Equity Group, L.P. (US$399.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STE

All STE fund holders →

FAQ

How long has CADEN CAPITAL PARTNERS, LP held STE?

CADEN CAPITAL PARTNERS, LP has disclosed STE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is CADEN CAPITAL PARTNERS, LP's current position in STE?

As of Q2 2026, CADEN CAPITAL PARTNERS, LP holds 946 shares of STE (STERIS PLC), valued at $199.20K, representing 2.40% of its reported portfolio and ranking #32.

Has CADEN CAPITAL PARTNERS, LP been buying or selling STE?

In the latest 13F filing (Q2 2026), CADEN CAPITAL PARTNERS, LP held unchanged its position in STE. The position peaked in Q4 2024 at 175.36K shares.

Which other funds hold STE?

Other major institutional holders of STE include Orbis Allan Gray Ltd, GENERATION INVESTMENT MANAGEMENT LLP, Select Equity Group, L.P., among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.